Andrew Fritz Email

VP Financial Planning and Analysis . Rhythm Pharmaceuticals

Current Roles

Employees:
300
Revenue:
$5.9M
About
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Rhythm's lead product candidate is setmelanotide, a first-in-class melanocortin-4 receptor (MC4R) agonist. Rhythm supports The Genetic Obesity Project (GeneticObesity.com) and the GO-ID Genotyping Study (GeneticObesityID.com).
Rhythm Pharmaceuticals Address
222 Berkeley Street
Boston, MA
United States

Past Companies

Rhythm Pharmaceuticals Inc.Vice President Financial Planning and Analysis
Akcea TherapeuticsSenior Director of Financial Planning & Analysis
Viant MedicalVice President, Franchise Finance

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.